Judith M Greer

researcher

Born 2000-01-01

Judith M Greer is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID01061043213.48
P2798Loop ID385740
P496ORCID iD0000-0003-4440-4309
P3829Publons author ID1250264
P1053ResearcherIDC-4945-2009

P734family nameGreerQ16870300
GreerQ16870300
GreerQ16870300
P735given nameJudithQ5954149
JudithQ5954149
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q37435137A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis.
Q63535316A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire
Q63535314An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Q45036480An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population
Q27012075Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis
Q48886486CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia.
Q60731232Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies
Q52150778Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome.
Q63535323Comparison of T suppressor factors from tumour-bearing mice and mice immunized with a monoclonal anti-idiotypic antibody
Q46056898Correlation of adrenomedullin gene expression in peripheral blood leukocytes with severity of ischemic stroke.
Q63535318Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis
Q63535320Distinctive molecular markers and biological activities in two tumour-specific murine T suppressor factors
Q57693313Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151
Q63535321Effects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cell-mediated immunity in vitro
Q50654275Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.
Q34472020Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein
Q63535312Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice
Q63535319Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice
Q82849874Immune activation in the peripheral blood of patients with acute ischemic stroke
Q28303348Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?
Q63535313Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein
Q50766428Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
Q78608096Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis
Q63535310Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
Q63535124Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis
Q53118085Investigation of the [-/A]8 and C1236T genetic variations within the human Toll-like receptor 3 gene for association with multiple sclerosis.
Q92196062Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia?
Q63535271Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke
Q37172971Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
Q45842759Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms.
Q49032270Orientation of myelin proteolipid protein in the oligodendrocyte cell membrane
Q57476157PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations
Q50644184Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
Q47687532Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
Q45845904Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis.
Q33645752Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease
Q98384953Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis-A Possible Cause of Constitutive NF-κB Activation
Q37862835Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms
Q37595548Sexual dimorphism in autoimmune disease.
Q51789015Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
Q51793107Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population.
Q38477340Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases
Q38287223The Role of HLA in MS Susceptibility and Phenotype
Q33804295The effect of ageing on human lymphocyte subsets: comparison of males and females
Q35487679The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis
Q28389137The role of epigenetic mechanisms and processes in autoimmune disorders
Q63535217Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis

Search more.